|
|
|
|
|
Legal status
Patent in force
| (51) | INT.CL. | C07K 16/28 | (2006.01) |
| A61P 7/02 | (2006.01) | ||
| A61P 7/06 | (2006.01) | ||
| A61P 37/00 | (2006.01) |
| (11) | Number of the document | 2654781 |
| (13) | Kind of document | T |
| (96) | European patent application number | 11851933.9 |
| Date of filing the European patent application | 2011-12-21 | |
| (97) | Date of publication of the European application | 2013-10-30 |
| (45) | Date of publication and mention of the grant of the patent | 2018-01-24 |
| (46) | Date of publication of the claims translation | 2018-08-10 |
| (86) | Number | PCT/US2011/066470 |
| Date | 2011-12-21 |
| (87) | Number | WO 2012/088265 |
| Date | 2012-06-28 |
| (30) | Number | Date | Country code |
| 97473910 | 2010-12-21 | US | |
| 201161529682 P | 2011-08-31 | US |
| (72) |
ROLLINS, Scott, US
ALVAREZ, Richard, US
ROTHER, Russell, US
KAWAR, Ziad, S., US
MCEVER, Rodger, P., US
|
| (73) |
Oklahoma Medical Research Foundation,
825 N.E. 13th Street, Oklahoma City, OK 73104,
US
NOVARTIS AG, Lichtstrasse 35, 4056 Basel, CH |
| (74) |
Aušra PAKĖNIENĖ,
AAA Law, A. Goštauto g. 40B, Verslo centras "Dvyniai", LT-03163 Vilnius,
LT
|
| (54) | Anti-P-selektino antikūnai ir jų panaudojimo būdai bei identifikacija |
| ANTI-P-SELECTIN ANTIBODIES AND METHODS OF THEIR USE AND IDENTIFICATION |
| Payment date | Validity (years) | Amount | |
| 2024-11-22 | 14 | 289.00 EUR |
| 2025-12-21 |